Suppr超能文献

中毒性休克综合征患者的纤溶变化;活性尿激酶型纤溶酶原激活物的释放

Fibrinolytic changes in a patient with toxic shock syndrome; release of active u-PA.

作者信息

Haj M A, Robbie L A, Croll A, Adey G D, Bennett B

机构信息

Department of Medicine & Therapeutics, University of Aberdeen Medical School, Foresterhill UK.

出版信息

Intensive Care Med. 1998 Mar;24(3):258-61. doi: 10.1007/s001340050561.

Abstract

OBJECTIVE

Definition of the changes in the activators of plasminogen, u-PA and t-PA, and examination of the possible generation of plasmin in the circulation in overwhelming sepsis.

DESIGN

Serial blood analysis starting 4 h after development of symptoms of toxic shock syndrome.

SETTING

Intensive care unit.

PATIENT

A previously healthy woman underwent endometrial ablation and rapidly thereafter developed staphylococcal toxic shock syndrome with organ failure. MEASUREMENT AND RESULT: t-PA, PAI-1, t-PA-PAI-1 complexes, plasminogen, fibrinogen and plasmin-alpha 2-antiplasmin complexes were measured serially by ELISA and free u-PA by SDS-PAGE with zymography. The onset of symptoms was accompanied by a rise of t-PA antigen-followed rapidly by PAI-1 antigen. Plasmin-alpha 2-antiplasmin complex was generated in large amounts but disappeared within hours. From day 3, free u-PA was detectable in the circulation without plasmin generation.

CONCLUSION

Despite the sustained presence of active u-PA in the circulation and of t-PA antigen at the onset of symptoms, plasmin-alpha 2-antiplasmin generation was largely suppressed by high levels of PAI-1. The suppression of plasmin generation by u-PA and t-PA may ensure the persistence of fibrin in the microcirculation and so contribute to organ failure.

摘要

目的

明确纤溶酶原激活剂尿激酶型纤溶酶原激活剂(u-PA)和组织型纤溶酶原激活剂(t-PA)的变化,并检测暴发性脓毒症时循环中纤溶酶的可能生成情况。

设计

在中毒性休克综合征症状出现后4小时开始进行系列血液分析。

地点

重症监护病房。

患者

一名既往健康的女性接受了子宫内膜切除术,此后迅速发展为伴有器官衰竭的葡萄球菌中毒性休克综合征。

测量与结果

通过酶联免疫吸附测定(ELISA)连续检测t-PA、纤溶酶原激活物抑制剂-1(PAI-1)、t-PA-PAI-1复合物、纤溶酶原、纤维蛋白原和纤溶酶-α2-抗纤溶酶复合物,通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)和酶谱法检测游离u-PA。症状出现时伴有t-PA抗原升高,随后PAI-1抗原迅速升高。大量生成纤溶酶-α2-抗纤溶酶复合物,但数小时内消失。从第3天起,循环中可检测到游离u-PA,但无纤溶酶生成。

结论

尽管症状出现时循环中持续存在活性u-PA和t-PA抗原,但高水平的PAI-1在很大程度上抑制了纤溶酶-α2-抗纤溶酶的生成。u-PA和t-PA对纤溶酶生成的抑制可能确保纤维蛋白在微循环中的持续存在,从而导致器官衰竭。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验